Pharmacologist and cancer researcher at Bristol Myers Squibb Company.
Education
- PhD, University of California, San Francisco (2008-2013)
Research Interests
Keywords:
Pharmacology
Drug Development
Cancer Research
Topics:
Pharmacology
Drug Development
Oncology
Professional Links
Selected Publications
S100A3 protein reduces PAH risk
Zhao W, Chen Y, Yu Z, Wang Z, He R, et al. Risk associated circulating biomarkers S100A3 identified in congenital heart disease-associated pulmonary arterial hypertension. Intractable Rare Dis Res. 2025;14:36. doi:10.5582/irdr.2024.01064
Related Products
Products associated with this researcher's work:
Related to: Heart+disease